Cure My Disease

Don't miss your cure!

 Log in / Sign up

New magnetic helmet aims to restore arm movement in stroke survivors

NCT ID NCT07277595

Not yet recruiting Symptom relief Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new, non-invasive brain stimulation technique called kTMP to help improve arm and hand function in people who have had a stroke. One hundred adults with chronic stroke-related arm weakness will receive either active or sham stimulation over 18 weeks. The goal is to see if this gentle magnetic stimulation can boost motor recovery and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
kTMP (kilohertz transcutaneous magnetic perturbations) device
What this could lead to
If it works, this could offer a new, non-invasive way to improve arm and hand movement for people who have had a stroke.
What could go wrong
This is an early-stage study with no prior results, so the treatment may not work better than a sham. The effects may also vary widely between individuals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARM WEAKNESS AS A CONSEQUENCE OF STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARM WEAKNESS AS A CONSEQUENCE OF STROKE CHRONIC STROKE PATIENTS STROKE

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of California, San Francisco

    San Francisco, California, 94158, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.